Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phospholipase Cgamma1 is required for metastasis development and progression.
Sala G, Dituri F, Raimondi C, Previdi S, Maffucci T, Mazzoletti M, Rossi C, Iezzi M, Lattanzio R, Piantelli M, Iacobelli S, Broggini M, Falasca M. Sala G, et al. Among authors: lattanzio r. Cancer Res. 2008 Dec 15;68(24):10187-96. doi: 10.1158/0008-5472.CAN-08-1181. Cancer Res. 2008. PMID: 19074886
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.
Corda G, Sala G, Lattanzio R, Iezzi M, Sallese M, Fragassi G, Lamolinara A, Mirza H, Barcaroli D, Ermler S, Silva E, Yasaei H, Newbold RF, Vagnarelli P, Mottolese M, Natali PG, Perracchio L, Quist J, Grigoriadis A, Marra P, Tutt AN, Piantelli M, Iacobelli S, De Laurenzi V, Sala A. Corda G, et al. Among authors: lattanzio r. J Pathol. 2017 Feb;241(3):350-361. doi: 10.1002/path.4841. Epub 2016 Dec 29. J Pathol. 2017. PMID: 27859262 Free PMC article.
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G. Capone E, et al. Among authors: lattanzio r. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989. Cancers (Basel). 2020. PMID: 33076448 Free PMC article.
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability.
Guerra E, Trerotola M, Relli V, Lattanzio R, Tripaldi R, Ceci M, Boujnah K, Pantalone L, Sacchetti A, Havas KM, Simeone P, Travali N, Querzoli P, Pedriali M, Roversi P, Iezzi M, Tinari N, Antolini L, Alberti S. Guerra E, et al. Among authors: lattanzio r. Mol Cancer Ther. 2023 Jun 1;22(6):790-804. doi: 10.1158/1535-7163.MCT-22-0352. Mol Cancer Ther. 2023. PMID: 36921314
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance.
Damiani V, Lamolinara A, Cicalini I, Cufaro MC, Del Pizzo F, Di Marco F, Del Boccio P, Dufrusine B, Hahne M, Lattanzio R, Pieragostino D, Iezzi M, Federici M, Turco MC, Maiorana A, Dionisi-Vici C, De Laurenzi V. Damiani V, et al. Among authors: lattanzio r. Mol Metab. 2023 Aug;74:101752. doi: 10.1016/j.molmet.2023.101752. Epub 2023 Jun 10. Mol Metab. 2023. PMID: 37308077 Free PMC article.
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.
Bibbò S, Capone E, Lovato G, Ponziani S, Lamolinara A, Iezzi M, Lattanzio R, Mazzocco K, Morini M, Giansanti F, De Laurenzi V, Whitfield J, Iacobelli S, Ippoliti R, Beaulieu ME, Soucek L, Sala A, Sala G. Bibbò S, et al. Among authors: lattanzio r. J Control Release. 2024 Oct;374:171-180. doi: 10.1016/j.jconrel.2024.08.009. Epub 2024 Aug 14. J Control Release. 2024. PMID: 39128771 Free article.
227 results